2022 American Transplant Congress
Semaglutide Tolerability and Efficacy in Patients with Chronic Kidney Disease Stage 4, 5 and End Stage Renal Disease
*Purpose: Obesity is often a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes with many transplant centers setting BMI cut…2022 American Transplant Congress
Expanding Access to Robotic Kidney Transplantation for Candidates with High BMI. A Training Tool for Transplant Centers
Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: Recently published literature has demonstrated favorable outcomes for Robotic Kidney Transplant (RKT) in high BMI recipients. The University of Illinois at Chicago (UIC) has…2022 American Transplant Congress
Epidemiology of Post Transplant Diabetes Mellitus
Renal Medicine Department, The Royal Hospital, Bausher, Oman
*Purpose: Diabetes mellitus (DM) is a common non-communicable disease and have serious metabolic complications that contribute to death, major cardiovascular events, organs failure, and increased…2022 American Transplant Congress
Gender Disparities in Kidney Transplantation Referral Vary by Age and Race in the Southeast US
1Emory University, Atlanta, GA, 2Medical University of South Carolina, Charleston, SC
*Purpose: Men (vs. women) are more likely to be waitlisted or receive a kidney transplant. Whether gender disparities exist in earlier transplant steps (i.e., referral)…2022 American Transplant Congress
Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study
*Purpose: The growing end stage kidney disease burden paired with substantial rates of obesity in the United States (US) has prompted increased approval of obese…2022 American Transplant Congress
The Impact of Obesity on Delayed Graft Function
1Royal Prince Alfred Hospital, Camperdown, Australia, 2University of Sydney, Camperdown, Australia
*Purpose: Obesity is increasingly prevalent among candidates for kidney transplantation. Outcomes for obese patients remain uncertain, as existing studies have shown conflicting short and longer-term…2022 American Transplant Congress
Tumor Suppressor Role of the Caveolar α1-na/k-atpase Signalosome in Nash Related Hepatocellular Carcinoma (HCC)
*Purpose: HCC is the second and fastest-growing cause of cancer- related mortality worldwide, with an estimate of 0.84million cases/year. In the Western countries, due to…2022 American Transplant Congress
Ventricular Modeling Following Bariatric Surgery Decreases Need for Heart Transplantation
*Purpose: For obese patients with congestive heart failure (CHF), aggressive weight loss has been associated with ventricular remodeling. Many have suggested offering bariatric surgery for…2022 American Transplant Congress
The Paradox of Lifestyle – Related Liver Disease: ASH and NASH
*Purpose: In the last decade, the burden of lifestyle-related chronic disease has been on the rise and is considered a growing serious public health concern.…2022 American Transplant Congress
Sarcopenia and Obesity in Renal Transplant Recipients – Effects on Graft and Patient Outcomes
The Royal London Hospital, London, United Kingdom
*Purpose: Body composition is associated with prognosis in a range of clinical settings, and patients with renal failure usually have significant comorbidities and are high…
- 1
- 2
- 3
- …
- 24
- Next Page »